Nate Shively Profile picture
Oct 22 12 tweets 9 min read
Oral Therapy for Bacteremia and Endocarditis

@IDwithNWD giving talk for @BradSpellberg

"No, you're not in the wrong room, and @BradSpellberg did not get younger and more handsome."

#IDWeek2022
#IDTwitter
Historical lesson first.

Where did the myth that we need IV for IE come from?

Have to go back a ways.

#IDWeek2022
The dooming quote.

#IDWeek2022
Oral antibiotic blood levels.

#IDWeek2022
Reality check - no data that IV is better, and it's riskier.

#IDWeek2022
Score card of trials. Doesn't look good for IV.

#IDWeek2022
Here's the data for oral vs IV in osteo.

#IDWeek2022
And the data for bacteremia.

#IDWeek2022
And finally, endocarditis.

I cut off the funnel plot on the one, sorry.

#IDWeek2022
Chutzpah.

#IDWeek2022
Summary.

Bunch of RCTs for oral, no contrary studies for IV.

#IDWeek2022
Finally, when to switch.

Fantastic talk from @IDwithNWD, standing in flawlessly for @BradSpellberg.

#IDWeek2022
#IDTwitter

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Nate Shively

Nate Shively Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NateShivelyMD

Oct 22
What drives physicians refusing ASP recommendations?

We looked into it.

Just got done presenting our #IDWeek2022 oral abstract.
#IDTwitter

🧵

1/ Image
First, there are a bunch of ways to do TeleASP, but especially the more "intense" models have shown success and can be as good as on-site programs.

Our prior work: academic.oup.com/cid/article/71…

SCORE trial from @E_Stenehjem et al.: academic.oup.com/cid/article/67…

#IDWeek2022

2/ Image
What do we know already about what influences rec acceptance?

Summary of prior work, including great work from @BRxAD - surgeons tend to be less accepting, and recs that reduce antibiotic exposure refused more.

3/ Image
Read 16 tweets
Oct 21
What's better for reducing unnecessary treatment of asymptomatic bacteriuria? Diagnostic stewardship or antibiotic stewardship?

@ValerieVaughnMD presenting the @SHEA_Epi featured oral abstract.

#IDWeek2022 ImageImage
Pathway to overuse and opportunities to intervene.

#IDWeek2022 Image
Diagnostic stewardship metric was ASB (treated or not) / +UCx

#IDWeek2022 ImageImage
Read 8 tweets
Oct 21
Bactrim is fine for most beta-hemolytic strep, folks.

Many of us were taught this one incorrectly because thymidine content in agar unregulated until 2006 so looked resistant in old studies.

Appreciate @SDoernberg clearing this one up in 2nd myth busters talk.

#IDWeek2022 ImageImageImageImage
Nice aside - dosing matters.

Most people I'm consulted on who fail oral treatment for true cellulitis are underdosed.

#IDWeek2022 Image
Clinical data on PCN vs TMP/SMX and Clinda vs TMP/SMX.

#IDWeek2022 ImageImageImageImage
Read 4 tweets
Oct 21
Nice follow up talk from @ValerieVaughnMD - always great stuff from her.

#IDWeek2022 Image
Anyone ever seen a patient like this?

(For hospitalists like @ValerieVaughnMD and those of us that review patients with ASP, every day, multiple times per day)

#IDWeek2022 ImageImageImageImage
A note that what we call overdiagnosis for infections, others may call inappropriate diagnosis.

#IDWeek2022 Image
Read 8 tweets
Oct 21
I don't know anyone that is more excited about urine than @Sonali_Advani.

Some highlights from her great talk this morning ⬇️

#IDWeek2022
Lots of factors go into inappropriate culturing.

Physicians more driven by labs, nurses by appearance/smell.

Education can help.

#IDWeek2022
Tough group is the 3rd box.

Yep.

#IDWeek2022
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(